 |
 |
 |
|
CTRP-3 is a biomarker for obesity, diabetes, and metabolic syndrome research.
Citations:- CTRP3 (Human) Globular Form recombinant 00082-01-100 had been used by Dr. Liling Wu on following research. Zhou Y , and Wu LL. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro. Arterioscler Thromb Vasc Biol. 2014 May;34(5): 1002-10. doi: 10.1161/ ATVBAHA.114.303301. Epub 2014 Feb 27.
- Yang Mu et al. "CTRP3 attenuates high-fat diet-induced male reproductive dysfunction in mice" DOI https://doi.org/10.1042/CS20180179 PubMed 29572383
- Yun Zhou et al. "Overexpression of C1q/Tumor Necrosis Factor–Related Protein-3 Promotes Phosphate-Induced Vascular Smooth Muscle Cell Calcification Both In Vivo and In Vitro" DOI: 10.1161/ATVBAHA.114.303301
- Ying Li et al. "Metabolic Plasticity in the Cellular Stress Response" (2018). Electronic Theses and Dissertations. Paper 3467. https://dc.etsu.edu/etd/3467/
- Mao Z, Yang L, Lu X, Tan A, Wang Y, Ding F, Xiao L, Qi X, Yu Y. C1QTNF3 in the murine ovary and its function in folliculogenesis. Reproduction. 2018 Apr;155(4):333-346. (Human gCTRP3 recombinant had been used by Dr. Yu in this research).
- Mei M, Qu LH, Cong X, Zhang Y, Xiang RL, Yu GY, Su JZ, Wu LL. CTRP3 promotes TNF-α-induced apoptosis and barrier dysfunction in salivary epithelial cells. Cell Signal. 2021 Sep;85:110042. doi: 10.1016/j.cellsig.2021.110042. Epub 2021 May 13. PMID: 33991612. (Human gCTRP3 recombinant 00082-01-100 had been used by Dr. Wu)
 
|
|
|
 |
|
 |
|